FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients--efficacy and microbiologic safety

Background Multidrug-resistant Gram-negative bacterial (MRGNB) infections represent a major public health threat. Cancer patients and, among them, hematological patients are most vulnerable to these infections. Gut colonization by MRGNB is a common phenomenon occurring during hospitalization and che...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Trials 2023, Vol.24 (1)
Hauptverfasser:	Moreno, Ainhoa Fernández, Lavín-Alconero, Lucía, de Ugarriza, Paula López, Blanco, Laura Solán, Hernández, Sara Cáceres, Burgués, Juan Miguel Bergua, de Miguel, María Izquierdo, Huerta, Ana Julia González, Zarzuela, Marta Polo, Boluda, Blanca, Humala, Karem, Calabuig, Maria Luisa, Amigo, Maria Luz, Casas, Marián Cuesta, del Mar García-Saiz, María, Verdugo, Ana Fernández, Domínguez, Javier Fernández, Bernal, Teresa
Format:	Report
Sprache:	eng
Schlagworte:	Cancer Care and treatment Chemotherapy Ciprofloxacin Diagnosis Fosfomycin Hematopoietic stem cells Neutropenia Patient outcomes Testing Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!